Journal: Diagnostics
Article Title: Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level
doi: 10.3390/diagnostics13243686
Figure Lengend Snippet: Advantages and disadvantages of FastBio-RBD TM (fluorescence immunoassay) and GenScript-cPASS TM (SVNT).
Article Snippet: GenScript-cPASS TM (SVNT) , - Scalable alternative in comparison to conventional neutralization assays - More sensitive in detecting neutralizing antibodies (nAbs) - Acceptable standard for various clinical and research settings , - Needs to be conducted in well-equipped immunology laboratories - ELISA readings require a skilled laboratory technician.
Techniques: Fluorescence, Clinical Proteomics, Inhibition, Binding Assay, Neutralization, Comparison, Enzyme-linked Immunosorbent Assay